Novo Nordisk
NVO
#109
Rank
โ‚น17.034 T
Marketcap
โ‚น3,864
Share price
0.96%
Change (1 day)
-11.13%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

EPS for Novo Nordisk (NVO)

EPS in 2023 (TTM): โ‚น235.80

According to Novo Nordisk's latest financial reports the company's current EPS (TTM) is โ‚น371.07. In 2022 the company made an earnings per share (EPS) of โ‚น204.10 an increase over its 2021 EPS that were of โ‚น187.23.

EPS history for Novo Nordisk from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)โ‚น235.8015.53%
2022โ‚น204.109.01%
2021โ‚น187.2315.08%
2020โ‚น162.6914.83%
2019โ‚น141.68-1.68%
2018โ‚น144.104.96%
2017โ‚น137.2931.08%
2016โ‚น104.74-10.33%
2015โ‚น116.8113.91%
2014โ‚น102.544.03%
2013โ‚น98.57-28.81%
2012โ‚น138.45108.9%
2011โ‚น66.2825.59%
2010โ‚น52.7735.01%
2009โ‚น39.09-9.17%
2008โ‚น43.0361.35%
2007โ‚น26.6728.96%
2006โ‚น20.6825.63%
2005โ‚น16.464.17%
2004โ‚น15.8013.55%
2003โ‚น13.9236.87%
2002โ‚น10.17-6.99%
2001โ‚น10.9321.56%
2000โ‚น8.9949.45%
1999โ‚น6.023.78%
1998โ‚น5.8012.15%
1997โ‚น5.1724.74%
1996โ‚น4.15

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
โ‚น66.77-82.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น2,905 682.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น186.25-49.81%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
โ‚น425.06 14.55%๐Ÿ‡บ๐Ÿ‡ธ USA